• Prof. Helen McShane (chair)
    Prof. Helen McShane (chair)Wellcome Trust Senior Clinical Research Fellow Professor of Vaccinology University of Oxford Oxford, United Kingdom
    • Prof. Peter Andersen, DVM, DMSc
      Prof. Peter Andersen, DVM, DMScVice President of Vaccine Research and Development Statens Serum Institut Copenhagen, Denmark
      • Dr Carol Holm-Hansen
        Dr Carol Holm-HansenSenior scientist Norwegian Institute of Public Health Oslo, Norway
        • Prof. Dr Dr h.c. Stefan H.E. Kaufmann
          Prof. Dr Dr h.c. Stefan H.E. KaufmannFounding Director Max-Planck-Institute for Infection Biology Berlin, Germany
          • Prof. Willem Hanekom
            Prof. Willem HanekomDeputy Director tuberculosis Bill & Melinda Gates Foundation Seattle, USA
            • Dr Camille Locht
              Dr Camille LochtResearch Director, French National Institute of Health and Medical Research (Inserm) Head of the Center for Infection and Immunity of Lille, Institut Pasteur de Lille, France.
              • Prof. Carlos Martin
                Prof. Carlos MartinProfessor of Microbiology University of Zaragoza Zaragoza, Spain
                • Dr Olivier Neyrolles
                  Dr Olivier NeyrollesCNRS Research Director Institute of Pharmacology & Structural Biology Toulouse, France
                  • Dr Gerd Zettlmeissl
                    Dr Gerd ZettlmeisslRepresentative of the Board of Directors of Aeras Former CEO Valneva SE (formerly Intercell AG) Vienna, Austria
                    • Dr Ann Rawkins
                      Dr Ann RawkinsTB project co-ordinator, Health Protection England
                      • Prof. Hazel M. Dockrell
                        Prof. Hazel M. DockrellProfessor of Immunology, Special Advisor on Overseas Partnerships in Africa, London School of Hygiene and Tropical Medicine, UK
                        • Dr Geneviève Inchauspé
                          Dr Geneviève InchauspéHead of the Department of Infectious Diseases, Transgene, Lyon, France
                          • Ingrid Murillo Jelsbak
                            Ingrid Murillo JelsbakClinical Research Director at Biofabri, Porriño, Spain
                            • Dr Jan T. Poolman
                              Dr Jan T. PoolmanHead Bacterial Vaccine Discovery and Early Development at the Janssen Pharmaceutical Companies of Johnson & Johnson, Leiden, The Netherlands
                              • Marie-Ange Demoitié
                                Marie-Ange DemoitiéTB Vaccine Project Leader, Vaccines Discovery & Development, GSK
                                • Olga Rué Clarós
                                  Olga Rué ClarósCEO Archivel Farma S.L. Badalona (Barcelona), Spain.